178 related articles for article (PubMed ID: 22370181)
1. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
[TBL] [Abstract][Full Text] [Related]
2. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
[TBL] [Abstract][Full Text] [Related]
3. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B
Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843
[TBL] [Abstract][Full Text] [Related]
4. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract][Full Text] [Related]
5. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
[TBL] [Abstract][Full Text] [Related]
7. Circulating endothelial progenitor cells and cardiovascular outcomes.
Werner N; Kosiol S; Schiegl T; Ahlers P; Walenta K; Link A; Böhm M; Nickenig G
N Engl J Med; 2005 Sep; 353(10):999-1007. PubMed ID: 16148285
[TBL] [Abstract][Full Text] [Related]
8. VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients.
Vroling L; Yuana Y; Schuurhuis GJ; van Hinsbergh VW; Gundy C; de Haas R; van Cruijsen H; Boven E; Hoekman K; Broxterman HJ
Thromb Haemost; 2007 Aug; 98(2):440-50. PubMed ID: 17721629
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
Brunner S; Theiss HD; Murr A; Negele T; Franz WM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
[TBL] [Abstract][Full Text] [Related]
10. High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.
Shao YY; Lin ZZ; Chen TJ; Hsu C; Shen YC; Hsu CH; Cheng AL
Oncology; 2011; 81(2):98-103. PubMed ID: 21986371
[TBL] [Abstract][Full Text] [Related]
11. An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood.
Hristov M; Schmitz S; Schuhmann C; Leyendecker T; von Hundelshausen P; Krötz F; Sohn HY; Nauwelaers FA; Weber C
Cytometry A; 2009 Oct; 75(10):848-53. PubMed ID: 19739088
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel.
Strijbos MH; Gratama JW; Schmitz PI; Rao C; Onstenk W; Doyle GV; Miller MC; de Wit R; Terstappen LW; Sleijfer S
Eur J Cancer; 2010 Jul; 46(11):2027-35. PubMed ID: 20399640
[TBL] [Abstract][Full Text] [Related]
13. High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma.
Yang B; Gu W; Peng B; Xu Y; Liu M; Che J; Geng J; Zheng J
J Urol; 2012 Dec; 188(6):2055-61. PubMed ID: 23088990
[TBL] [Abstract][Full Text] [Related]
14. Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartments.
Udi J; Wider D; Kleber M; Ihorst G; Müller A; Wäsch R; Engelhardt M
Leuk Res; 2011 Sep; 35(9):1265-8. PubMed ID: 21684596
[TBL] [Abstract][Full Text] [Related]
15. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
20. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
